Skip to main content

Advertisement

Fig. 3 | Clinical Epigenetics

Fig. 3

From: Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer

Fig. 3

Kaplan-Meier survival curves for HNSCC patients. DFS for (a) all 165 HNSCC cases, (b) tumor size in T1 and T2 cases (n = 84), (c) tumor size T3 and T4 cases (n = 81), (d) lymph node status N0 cases (n = 74), (e) lymph node status N+ cases (n = 91), (f) stage I and II cases (n = 49), and (g) stage III and IV cases (n = 116). Gray and black lines indicate patients without and with methylation, respectively

Back to article page